{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:13:22Z","timestamp":1776352402401,"version":"3.51.2"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI184071"],"award-info":[{"award-number":["U01 AI184071"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3AI190386"],"award-info":[{"award-number":["UG3AI190386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.iac.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:32:00Z","timestamp":1772627520000},"page":"275-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug Anaphylaxis"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9999-1275","authenticated-orcid":false,"given":"Timothy G.","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Alvarez-Arango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jaip.2024.02.019","article-title":"Non-IgE-mediated immediate drug-induced hypersensitivity reactions","volume":"12","author":"Alvarez-Arango","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/all.16576","article-title":"Endotypes in immune mediated drug reactions: present and future of relevant biomarkers. An EAACI task force report","volume":"80","author":"Mayorga","year":"2025","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/1381612829666221025091827","article-title":"Recent knowledge and insights on the mechanisms of immediate hypersensitivity and anaphylaxis: IgE\/FcepsilonRI- and Non-IgE\/FcepsilonRI-dependent anaphylaxis","volume":"29","author":"Ebo","year":"2023","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cea.14594","article-title":"Defining optimal basophil passive sensitisation parameters","volume":"55","author":"Alvarez-Arango","year":"2025","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaip.2022.12.014","article-title":"Allergenic and mas-related G protein-coupled receptor X2-activating properties of drugs: resolving the two","volume":"11","author":"Sabato","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/all.15933","article-title":"Biomarkers of immediate drug hypersensitivity","volume":"79","author":"Mayorga","year":"2024","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.iac.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.jaip.2024.07.028","article-title":"A skin testing strategy for non-IgE-mediated reactions associated with vancomycin","volume":"12","author":"Lyu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00403-025-03971-z","article-title":"Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies","volume":"317","author":"Saxena","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.iac.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4939-7352-1_13","article-title":"Analysis of complement activation by nanoparticles","volume":"1682","author":"Neun","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/all.15612","article-title":"Different phenotypes of drug-induced anaphylaxis-Data from the European anaphylaxis registry","volume":"78","author":"Hanschmann","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2023.08.018","article-title":"United states drug allergy registry (USDAR) grading scale for immediate drug reactions","volume":"152","author":"Khan","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/ijerph18010333","article-title":"Comorbidities and cofactors of anaphylaxis in patients with moderate to severe anaphylaxis. Analysis of data from the anaphylaxis registry for west pomerania province, Poland","volume":"18","author":"Poziomkowska-G\u0119sicka","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2013.08.012","article-title":"Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up","volume":"2","author":"Banerji","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaip.2014.07.011","article-title":"Outcomes of allergy\/immunology follow-up after an emergency department evaluation for anaphylaxis","volume":"3","author":"Campbell","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9S","key":"10.1016\/j.iac.2026.01.004_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaip.2020.08.002","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: general concepts","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jaip.2021.10.066","article-title":"Reliability of early and late testing for suspected perioperative hypersensitivity","volume":"10","author":"van der Poorten","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jaci.2020.04.058","article-title":"Accuracy of penicillin allergy diagnostic tests: a systematic review and meta-analysis","volume":"147","author":"Sousa-Pinto","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2026.01.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113101","article-title":"Detection of drug-specific immunoglobulin E (IgE) and acute mediator release for the diagnosis of immediate drug hypersensitivity reactions","volume":"496","author":"Brockow","year":"2021","journal-title":"J Immunol Methods"},{"issue":"5","key":"10.1016\/j.iac.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.anai.2015.02.002","article-title":"The utility of specific IgE testing to chlorhexidine in the investigation of perioperative adverse reactions","volume":"114","author":"Anderson","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jaip.2019.10.014","article-title":"A one-bag rapid desensitization protocol for paclitaxel hypersensitivity: a noninferior alternative to a multi-bag rapid desensitization protocol","volume":"8","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.iac.2026.01.004_bib27","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.jaip.2021.06.024","article-title":"One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: a five-year experience","volume":"9","author":"Sala-Cunill","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaip.2019.11.035","article-title":"Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: a retrospective population-based study","volume":"8","author":"Liang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.iac.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.jaip.2022.08.045","article-title":"The combined use of chronological and morphological criteria in the evaluation of immediate penicillin reactions: evidence from a large study","volume":"10","author":"Romano","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0091-6749(81)90180-9","article-title":"Skin testing to detect penicillin allergy","volume":"68","author":"Sullivan","year":"1981","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2026.01.004_bib31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0091-6749(99)70439-2","article-title":"Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics","volume":"103","author":"Blanca","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71083-x","article-title":"Penicillin causes non-allergic anaphylaxis by activating the contact system","volume":"10","author":"Gao","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.iac.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.jaip.2020.12.051","article-title":"Piperacillin-tazobactam hypersensitivity: a large, multicenter analysis","volume":"9","author":"Casimir-Brown","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jaip.2019.03.018","article-title":"Flucloxacillin hypersensitivity: patient outcomes in a multicenter retrospective study","volume":"7","author":"Kennard","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18176\/jiaci.0390","article-title":"Anaphylaxis to clavulanic acid: a 7-year survey","volume":"29","author":"Silveira","year":"2019","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/all.13435","article-title":"Incidence of cephalosporin-induced anaphylaxis and clinical efficacy of screening intradermal tests with cephalosporins: a large multicenter retrospective cohort study","volume":"73","author":"Yang","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.jaip.2020.11.025","article-title":"Perioperative allergic reactions: allergy assessment and subsequent anesthesia","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib39","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.bja.2024.01.044","article-title":"Epidemiology of perioperative anaphylaxis in France in 2017-2018: the 11th GERAP survey","volume":"132","author":"Tacquard","year":"2024","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.iac.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11882-024-01171-9","article-title":"Cephalosporin allergy: updates on diagnostic testing","volume":"24","author":"Chow","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in beta-lactam allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.jaip.2019.05.038","article-title":"Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses","volume":"7","author":"Picard","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2026.01.004_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0021","article-title":"Assessment of the frequency of dual allergy to penicillins and cefazolin: a systematic review and meta-analysis","volume":"156","author":"Sousa-Pinto","year":"2021","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.iac.2026.01.004_bib44","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.jaip.2020.04.051","article-title":"Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones","volume":"8","author":"Dona","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.iac.2026.01.004_bib45","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2165\/00002018-200629110-00008","article-title":"Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use","volume":"29","author":"Sachs","year":"2006","journal-title":"Drug Saf"},{"issue":"11","key":"10.1016\/j.iac.2026.01.004_bib46","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1365-2222.2009.03338.x","article-title":"Diagnostic testing in suspected fluoroquinolone hypersensitivity","volume":"39","author":"Seitz","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib47","article-title":"Evaluation of immediate vancomycin-induced hypersensitivity reaction to severe perioperative anaphylaxis","volume":"4","author":"Gansert","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/039463201402700116","article-title":"Azithromycin anaphylaxis in children","volume":"27","author":"Mori","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"20","key":"10.1016\/j.iac.2026.01.004_bib49","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1002\/cam4.4252","article-title":"Severe anaphylaxis caused by intravenous anti-cancer drugs","volume":"10","author":"Horita","year":"2021","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.iac.2026.01.004_bib50","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/cea.14011","article-title":"Chemotherapy-induced anaphylaxis and fatal anaphylaxis in the United States: incidence and risk factors","volume":"51","author":"Bojanini","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/all.15113","article-title":"Hypersensitivity reactions to chemotherapy: an EAACI position paper","volume":"77","author":"Pagani","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.iac.2014.04.003","article-title":"Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses","volume":"34","author":"Baldo","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.iac.2026.01.004_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.anai.2020.01.010","article-title":"Evaluation of hypersensitivity reactions to cancer chemotherapeutic agents in pediatric patients","volume":"124","author":"Turgay Yagmur","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaip.2024.12.021","article-title":"Risk factors of hypersensitivity reactions to carboplatin: a systematic review and meta-analysis","volume":"13","author":"Jang","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2021.04.018","article-title":"Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: a retrospective analysis of clinical outcomes and systematic review of literature","volume":"162","author":"Giannone","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.iac.2026.01.004_bib56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.alit.2024.03.003","article-title":"Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions","volume":"73","author":"Hsu","year":"2024","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib57","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12016-021-08877-y","article-title":"Hypersensitivity reactions to platinum agents and taxanes","volume":"62","author":"Tsao","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.01.004_bib58","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jaip.2020.02.013","article-title":"Endophenotyping oxaliplatin hypersensitivity: personalizing desensitization to the atypical platin","volume":"8","author":"Silver","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib59","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaip.2015.07.003","article-title":"Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions","volume":"3","author":"Lax","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/10600280221093594","article-title":"Outcomes of a undiluted, one-bag desensitization protocol for chemotherapeutic agents","volume":"57","author":"Iglesias-Santamar\u00eda","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12016-023-08968-y","article-title":"Hypersensitivity reactions to taxanes: a comprehensive and systematic review of the efficacy and safety of desensitization","volume":"65","author":"Villarreal-Gonz\u00e1lez","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib62","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaip.2018.09.018","article-title":"Role of skin tests in the diagnosis of immediate hypersensitivity reactions to taxanes: results of a multicenter study","volume":"7","author":"Pagani","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2026.01.004_bib63","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1398-9995.2006.01058.x","article-title":"Adverse side-effects to biological agents","volume":"61","author":"Pichler","year":"2006","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.iac.2026.01.004_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11882-022-01048-9","article-title":"Adverse reactions to biologic medications used in allergy and immunology diseases","volume":"22","author":"Chow","year":"2022","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.iac.2026.01.004_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2025.101065","article-title":"Comparison of three-bag and single-bag protocols in rapid drug desensitization with chemotherapeutic and biological agents","volume":"18","author":"Gul","year":"2025","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.iac.2026.01.004_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fphar.2020.00503","article-title":"Evaluation of subjects experiencing allergic reactions to non-steroidal anti-inflammatory drugs: clinical characteristics and drugs involved","volume":"11","author":"P\u00e9rez-S\u00e1nchez","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.004_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000510335","article-title":"Descriptive analysis of cross-reactive anaphylaxis as a different clinical subtype of nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity","volume":"182","author":"V\u00e1squez","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2016.10.021","article-title":"Current knowledge and management of hypersensitivity to aspirin and NSAIDs","volume":"5","author":"Laidlaw","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib69","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaip.2024.02.042","article-title":"A US-based multicenter retrospective report of perioperative anaphylaxis, 2010-2021","volume":"12","author":"Gonzalez-Estrada","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib70","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bja.2024.05.025","article-title":"Incidence of and risk factors for paediatric perioperative anaphylaxis in the USA","volume":"133","author":"Krase","year":"2024","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.iac.2026.01.004_bib71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaip.2017.03.016","article-title":"Current knowledge and management of hypersensitivity to perioperative drugs and radiocontrast media","volume":"5","author":"Hsu Blatman","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.01.004_bib72","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.bja.2019.01.033","article-title":"Chlorhexidine allergy in the perioperative setting: a narrative review","volume":"123","author":"Rose","year":"2019","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.iac.2026.01.004_bib73","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/SLA.0000000000004061","article-title":"Anaphylactic reaction rates to blue dyes used for sentinel lymph node mapping: systematic review and meta-analysis","volume":"273","author":"Perenyei","year":"2021","journal-title":"Ann Surg"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:31:37Z","timestamp":1776349897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856126000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0889856126000044"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.01.004","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}